These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10408146)

  • 1. [Comparative presentation of current economic evaluation studies for phenylketonuria screening].
    Ahrens D; Güntert B; Brand A
    Gesundheitswesen; 1999 Apr; 61(4):190-6. PubMed ID: 10408146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of establishing a neonatal screening programme for phenylketonuria in Libya.
    Sladkevicius E; Pollitt RJ; Mgadmi A; Guest JF
    Appl Health Econ Health Policy; 2010; 8(6):407-20. PubMed ID: 21043542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
    Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
    PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism.
    Dhondt JL; Farriaux JP; Sailly JC; Lebrun T
    J Inherit Metab Dis; 1991; 14(4):633-9. PubMed ID: 1749228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.
    Lord J; Thomason MJ; Littlejohns P; Chalmers RA; Bain MD; Addison GM; Wilcox AH; Seymour CA
    J Epidemiol Community Health; 1999 Mar; 53(3):179-86. PubMed ID: 10396496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for inborn errors of metabolism: a systematic review.
    Seymour CA; Thomason MJ; Chalmers RA; Addison GM; Bain MD; Cockburn F; Littlejohns P; Lord J; Wilcox AH
    Health Technol Assess; 1997; 1(11):i-iv, 1-95. PubMed ID: 9483156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A cost-benefit evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism].
    Gu X; Wang J; Ye J; Cheng X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):147-9. PubMed ID: 11860921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded newborn screening using tandem mass spectrometry.
    Fearing MK; Levy HL
    Adv Pediatr; 2003; 50():81-111. PubMed ID: 14626484
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism.
    Geelhoed EA; Lewis B; Hounsome D; O'leary P
    J Paediatr Child Health; 2005 Nov; 41(11):575-9. PubMed ID: 16398841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economic issues of screening programmes.
    Wildner M
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S5-7. PubMed ID: 14595558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
    Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
    Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-benefit analysis of hyperphenylalaninemia due to 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency: for consideration of expanded newborn screening in Hong Kong.
    Lee HH; Mak CM; Poon GW; Wong KY; Lam CW
    J Med Screen; 2014 Jun; 21(2):61-70. PubMed ID: 24803483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylketonuria in South Africa. A report on the status quo.
    Hitzeroth HW; Niehaus CE; Brill DC
    S Afr Med J; 1995 Jan; 85(1):33-6. PubMed ID: 7784915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economic analysis of the neonatal screening program in Japan.
    Hisashige A
    Int J Technol Assess Health Care; 1994; 10(3):382-91. PubMed ID: 8071001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylketonuria screening in the Republic of Macedonia.
    Kocova M; Anastasovska V
    Orphanet J Rare Dis; 2016 Aug; 11(1):112. PubMed ID: 27496147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economics of tandem mass spectrometry screening of neonatal inherited disorders.
    Pandor A; Eastham J; Chilcott J; Paisley S; Beverley C
    Int J Technol Assess Health Care; 2006; 22(3):321-6. PubMed ID: 16984060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylketonuria (PKU): screening and management.
    NIH Consens Statement; 2000 Oct 16-18; 17(3):1-33. PubMed ID: 11757784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective study.
    Toktaş İ; Sarıbaş S; Canpolat S; Erdem Ö; Özbek MN
    Turk J Pediatr; 2022; 64(6):985-992. PubMed ID: 36583880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular studies and prenatal diagnosis of phenylketonuria in Chinese patients.
    Fan GX; Qing LX; Jun Y; Mei Z
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():63-5. PubMed ID: 11400788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.